Telehealth and digital platforms New telehealth and digital platforms provide opportunities to deliver personalized nutrition support for individuals on GLP-1s
It does not suppress appetite or slow gastric emptying
ProMBS addresses these challenges by embedding compliance and performance safeguards into every step of the billing cycle
Similar to naturally occurring growth hormone-releasing hormone (GHRH), modified GRF 1-29 binds to the GHRH receptor in order to increase the rate at which GH is secreted
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
Accelerating progress in obesity prevention: solving the weight of the nation